Jiangsu Hengrui Medicine
600276.SS
#437
Rank
NZ$91.10 B
Marketcap
NZ$13.73
Share price
-1.46%
Change (1 day)
25.23%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

Half-year Reports

Thumbnail Jiangsu Hengrui Medicine
 Half-year Report 2025-h1

Half-year Report 2025-h1

Language: Chinese

View Half-year Report